Impact of a school-based water and hygiene intervention on child health and school attendance in Addis Ababa, Ethiopia: a cluster-randomised controlled trial

Abstract

Background Water, sanitation and hygiene (WASH) interventions in schools may improve the health and school attendance of schoolchildren, particularly among post-menarcheal girls, but existing evidence is mixed. We examined the impact of an urban WASH in schools programme (Project WISE) on child health and attendance. Methods The WISE cluster-randomised trial, conducted in 60 public primary schools in Addis Ababa, Ethiopia over one academic year, enrolled 2-4 randomly selected classes per school (approximately 100 pupils) from grades 2-8 (aged 7-16) in an 'open cohort'. Schools were assigned 1:1 by stratified randomisation to receive the intervention during the 2021/22 academic year or the 2022/23 academic year (waitlist control). Masking was not possible. The intervention included improvements to drinking water storage, filtration and access, alongside handwashing stations and behaviour change promotion. Planned improvements to sanitation facilities were not realised. At four unannounced classroom visits between March and June 2022 (post-intervention, approximately every four weeks), enumerators recorded primary outcomes of roll-call absence, and pupil-reported respiratory illness and diarrhoea in the past seven days among pupils present. Analysis was by intention-to-treat. This study is registered with ClinicalTrials.gov, number NCT05024890. Findings Of 83 eligible schools, 60 were randomly selected and assigned. In total, 6229 eligible pupils were enrolled (median per school 101.5; IQR 94-112), with 5987 enrolled at study initiation (23rd November-22nd December 2021) and the remaining 242 during follow-up. Data were available on roll-call absence for 6166 pupils (99.0%), and on pupil-reported illness for 6145 pupils (98.6%). We observed a 16% relative reduction in the odds of pupil-reported respiratory illness in the past seven days during follow-up in intervention schools vs. control schools (aOR 0.84; 95% CI 0.71-1.00; p=0.046). No effect was observed on pupil-reported diarrhoea in the past seven days (aOR 1.15; 95% CI 0.84-1.59; p=0.39) nor roll-call absence (aOR 1.07; 95% 0.83-1.38; p=0.59). There was a small increase in menstrual care self-efficacy (aMD 3.32 on 0-100 scale; 95% CI 0.05-6.59), and no effects on the other health, wellbeing and absence secondary outcomes. Interpretation This large-scale intervention to improve WASH conditions in schools across a large city had a borderline impact on respiratory illness among schoolchildren but no effect on diarrhoeal disease nor pupil absence. Future research should establish the relationships between WASH-related illness and absence and other downstream educational outcomes. Funding Children's Investment Fund Foundation.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT05024890

Clinical Protocols

https://doi.org/10.6084/m9.figshare.22194298

Funding Statement

This study was funded by the Children's Investment Fund Foundation.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The London School of Hygiene & Tropical Medicine Research Ethics Committee (reference 17761), and the National Research Ethics Review Committee of Ethiopia (NRERC; reference A/A/H/10H02/227) gave ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All data produced in the present study will be made available in the London School of Hygiene & Tropical Medicine's Data Repository (https://datacompass.lshtm.ac.uk) with publication.

留言 (0)

沒有登入
gif